GGrantIndex
Sort

51,570 grants matching autoimmune disease

Reducing innate inflammation in new onset T1D with Lactobacillus plantarum

$613,250
Martin John Hessner · Medical College Of Wisconsin · R01 · FY2022 · DK

Phase 2 Proof-of-Concept Efficacy of BT-11 in Crohn's Disease Patients

$613,188
Simon Lichtiger · Landos Biopharma, Inc. · R01 · FY2022 · DK

Autoantibodies Define Scleroderma Subgroups with Distinct Relationships to Cancer

$613,058
Ami Aalok Shah · Johns Hopkins University · R01 · FY2022 · AR

Role of Costimulation in Control of the Effector and Regulatory T Cell Balance

$613,015
Arlene H Sharpe · Yale University · P01 · FY2013 · AI

TrialNet: University of Florida Clinical Center and Network

$613,004
Desmond Arthur Schatz · University Of Florida · U01 · FY2009 · DK

Determinants of Post-Treatment Phenotypes in Lyme Disease

$612,995
John Aucott · Johns Hopkins University · R01 · FY2025 · AI

T cell receptor-activated autophagy as a regulator of T cell effector responses

$612,989
Brian Schaefer · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2021 · AI

T cell receptor-activated autophagy as a regulator of T cell effector responses

$612,897
Brian Schaefer · Henry M. Jackson Fdn For The Adv Mil/Med · R01 · FY2019 · AI

Regulatory mechanisms governing Th17 cell effector identity and plasticity

$612,894
Maria Ciofani · Duke University · R01 · FY2025 · AI

Airway inflammation and fear: elucidating immune mediators and neural substrates

$612,853
Renu Sah · University Of Cincinnati · R01 · FY2025 · MH

Trainet: Diabetes Type 1 Prevention

$612,812
Peter A Gottlieb · University Of Colorado Denver · U01 · FY2011 · DK

Antibody modulation of neural endocrine networks

$612,798
Betty Diamond · Feinstein Institute For Medical Research · P01 · FY2015 · AI

Deciphering the role of noncoding variation in the pathogenesis of multiple sclerosis

$612,784
Maria Ciofani · Duke University · R01 · FY2024 · AI

Risk Factors for Microscopic Colitis

$612,783
Robert S Sandler · Univ Of North Carolina Chapel Hill · R01 · FY2018 · DK

Cellular Therapy for Type 1 Diabetes using Mesenchymal Stem Cells

$612,705
Hongjun Wang · Medical University Of South Carolina · R01 · FY2024 · DK

Molecular Mechanisms and Treatment Of Autoimmunity In Man And Animal Models

$612,659
Michael Lenardo · Niaid Extramural Activities · Z01 · FY2007 · AI

Microbial Disruption of Dendritic Cell Maturation and Function

$612,657
Caroline A Genco · Tufts University Boston · R01 · FY2021 · AI

Risk Factors for Microscopic Colitis

$612,648
Robert S Sandler · Univ Of North Carolina Chapel Hill · R01 · FY2019 · DK

Development of Immunologic therapies against uveitis

$612,616
Charles E Egwuagu · National Eye Institute · ZIA · FY2022 · EY

A Toolkit for Analysis and Visualization of Preclinical Rodent Neuroimaging Experiments

$612,523
David W Shattuck · University Of California Los Angeles · R01 · FY2023 · NS

A Toolkit for Analysis and Visualization of Preclinical Rodent Neuroimaging Experiments

$612,523
David W Shattuck · University Of California Los Angeles · R01 · FY2025 · NS

PRECLINICAL STRATEGIES FOR TOLERANCE TO ISLET ALLOGRAFTS

$612,404
University Of Miami School Of Medicine · R01 · FY2000 · DK

Multiplexed single cell cytokine secretion assay

$612,371
Lawrence Michael Kauvar · Experimed Bioscence, Inc. · R44 · FY2006 · AI

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2023 · EB

Single cell characterization of the biomaterial immune and stromal response

$612,340
Jennifer Hartt Elisseeff · Johns Hopkins University · R01 · FY2022 · EB